Searched for: active:yes
exclude-minors:true
Department/Unit:Medicine
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease
Singh, Arushi; Zhang, Robert S; Bangalore, Sripal
The role of revascularization and percutaneous coronary intervention (PCI) in patients with acute coronary syndrome is well established. However, the incremental value of revascularization over guideline-directed medical therapy is controversial. Currently available data supports the use of PCI to improve angina and quality of life for chronic coronary disease and heart failure (HF). However, there is insufficient data to support revascularization with PCI to improve mortality, reduce cardiovascular events, or improve ejection fraction over medical therapy alone. Additional trials are necessary to identify HF patients who may benefit from revascularization, and the optimal revascularization strategy for this population.
PMID: 43003527
ISSN: 2211-7466
CID: 6075753
Optimizing Team Integration of Critical Care Pharmacists: A History of Critical Care Pharmacy Practice and Evolving Definition of "Optimal Practice"
Smith, Susan E; Bektas, Aeryana N; Henry, Kelli; Heavner, Mojdeh S; Papadopoulos, John; Sikora, Andrea
Critical Care Pharmacists (CCPs) are essential members of the intensive care unit (ICU) team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights best practices for optimal CCP integration, including optimal patient-to-pharmacist ratios, participation in interprofessional rounds, team-based practice models, and expanded coverage across all shifts. The Triple Domain framework is useful to evaluate CCP value across patients, health care teams, and institutions. Best practices include an ICU patient-to-CCP ratio of less than or equal to 15:1 and inclusion of CCPs on daily interprofessional rounds.
PMID: 43003540
ISSN: 1557-8232
CID: 6075758
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease
Singh, Arushi; Zhang, Robert S; Bangalore, Sripal
The role of revascularization and percutaneous coronary intervention (PCI) in patients with acute coronary syndrome is well established. However, the incremental value of revascularization over guideline-directed medical therapy is controversial. Currently available data supports the use of PCI to improve angina and quality of life for chronic coronary disease and heart failure (HF). However, there is insufficient data to support revascularization with PCI to improve mortality, reduce cardiovascular events, or improve ejection fraction over medical therapy alone. Additional trials are necessary to identify HF patients who may benefit from revascularization, and the optimal revascularization strategy for this population.
PMID: 43003527
ISSN: 2211-7466
CID: 6075755
Optimizing Team Integration of Critical Care Pharmacists: Where We Go Next
Smith, Susan E; Henry, Kelli; Papadopoulos, John; Sikora, Andrea; Bektas, Aeryana N; Heavner, Mojdeh S
Critical care pharmacists (CCPs) are essential members of the intensive care unit team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights barriers to optimal integration of CCPs within multidisciplinary teams as well as opportunities to address them. Persistent barriers include financial, workforce, data, interprofessional, and regulatory. Strategies to address these gaps may involve standardized metrics, innovative staffing models, and research to strengthen evidence-based implementation. Metrics should include all members of the Stakeholder Triad and should include a mix of workload metrics, safety and efficacy metrics, and work-design metrics.
PMID: 43003541
ISSN: 1557-8232
CID: 6075759
Optimizing Team Integration of Critical Care Pharmacists: A History of Critical Care Pharmacy Practice and Evolving Definition of "Optimal Practice"
Smith, Susan E; Bektas, Aeryana N; Henry, Kelli; Heavner, Mojdeh S; Papadopoulos, John; Sikora, Andrea
Critical Care Pharmacists (CCPs) are essential members of the intensive care unit (ICU) team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights best practices for optimal CCP integration, including optimal patient-to-pharmacist ratios, participation in interprofessional rounds, team-based practice models, and expanded coverage across all shifts. The Triple Domain framework is useful to evaluate CCP value across patients, health care teams, and institutions. Best practices include an ICU patient-to-CCP ratio of less than or equal to 15:1 and inclusion of CCPs on daily interprofessional rounds.
PMID: 43003540
ISSN: 1557-8232
CID: 6075757
Percutaneous Coronary Intervention for Heart Failure due to Coronary Artery Disease
Singh, Arushi; Zhang, Robert S; Bangalore, Sripal
The role of revascularization and percutaneous coronary intervention (PCI) in patients with acute coronary syndrome is well established. However, the incremental value of revascularization over guideline-directed medical therapy is controversial. Currently available data supports the use of PCI to improve angina and quality of life for chronic coronary disease and heart failure (HF). However, there is insufficient data to support revascularization with PCI to improve mortality, reduce cardiovascular events, or improve ejection fraction over medical therapy alone. Additional trials are necessary to identify HF patients who may benefit from revascularization, and the optimal revascularization strategy for this population.
PMID: 43003527
ISSN: 2211-7466
CID: 6075754
Optimizing Team Integration of Critical Care Pharmacists: A History of Critical Care Pharmacy Practice and Evolving Definition of "Optimal Practice"
Smith, Susan E; Bektas, Aeryana N; Henry, Kelli; Heavner, Mojdeh S; Papadopoulos, John; Sikora, Andrea
Critical Care Pharmacists (CCPs) are essential members of the intensive care unit (ICU) team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights best practices for optimal CCP integration, including optimal patient-to-pharmacist ratios, participation in interprofessional rounds, team-based practice models, and expanded coverage across all shifts. The Triple Domain framework is useful to evaluate CCP value across patients, health care teams, and institutions. Best practices include an ICU patient-to-CCP ratio of less than or equal to 15:1 and inclusion of CCPs on daily interprofessional rounds.
PMID: 43003540
ISSN: 1557-8232
CID: 6075756
Optimizing Team Integration of Critical Care Pharmacists: Where We Go Next
Smith, Susan E; Henry, Kelli; Papadopoulos, John; Sikora, Andrea; Bektas, Aeryana N; Heavner, Mojdeh S
Critical care pharmacists (CCPs) are essential members of the intensive care unit team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights barriers to optimal integration of CCPs within multidisciplinary teams as well as opportunities to address them. Persistent barriers include financial, workforce, data, interprofessional, and regulatory. Strategies to address these gaps may involve standardized metrics, innovative staffing models, and research to strengthen evidence-based implementation. Metrics should include all members of the Stakeholder Triad and should include a mix of workload metrics, safety and efficacy metrics, and work-design metrics.
PMID: 43003541
ISSN: 1557-8232
CID: 6075761
Optimizing Team Integration of Critical Care Pharmacists: Where We Go Next
Smith, Susan E; Henry, Kelli; Papadopoulos, John; Sikora, Andrea; Bektas, Aeryana N; Heavner, Mojdeh S
Critical care pharmacists (CCPs) are essential members of the intensive care unit team who provide comprehensive medication management to improve patient outcomes, safety, and cost efficiency. This article highlights barriers to optimal integration of CCPs within multidisciplinary teams as well as opportunities to address them. Persistent barriers include financial, workforce, data, interprofessional, and regulatory. Strategies to address these gaps may involve standardized metrics, innovative staffing models, and research to strengthen evidence-based implementation. Metrics should include all members of the Stakeholder Triad and should include a mix of workload metrics, safety and efficacy metrics, and work-design metrics.
PMID: 43003541
ISSN: 1557-8232
CID: 6075760
Heterogeneity in proteomic risk factors for coronary heart disease by sex and menopause status
Herold, Janina M; Surapaneni, Aditya; Coresh, Josef; Mavromatis, Lucas; Ruggles, Kelly V; Boerwinkle, Eric; Reynolds, Harmony; Ballantyne, Christie M; Yu, Bing; Flaherty, Carina; Grams, Morgan E
BACKGROUND/UNASSIGNED:Coronary heart disease (CHD) is the leading cause of morbidity and mortality worldwide, yet current prediction tools do not fully capture sex differences in risk. Menopause further modifies women's risk of CHD, but underlying molecular mechanisms are not well understood. Proteomic profiling may provide new insights into these mechanisms. METHODS/UNASSIGNED:We analyzed 4,877 SomaScan™-based plasma proteins in 10,034 Atherosclerosis Risk in Communities (ARIC) participants. Using linear regression, we identified sex- and menopause-related differences in circulating protein concentrations. We performed pathway enrichment analyses to capture underlying biological mechanisms. To evaluate the associations between proteins and incident CHD and differences by sex or menopause status, we applied Cox regression. Finally, we used LASSO regression to identify proteins that improve CHD risk prediction beyond an established clinical model. RESULTS/UNASSIGNED:We observed significant differences in circulating proteins by sex and menopausal status, including early changes during the menopausal transition. We found protein associations with incident CHD differed markedly by sex and menopausal stage: eight proteins were associated with CHD in men, compared with 54 in women, and six and 17 proteins in peri‑ and postmenopausal women, respectively. In risk prediction analyses, adding sex-specific protein panels improved CHD prediction (ΔC-statistic=0.05 in men and 0.03 in women), with similar improvement across menopausal stages. CONCLUSIONS/UNASSIGNED:Proteomic profiles underlying CHD risk differ substantially by sex and menopausal stage. These findings suggest potential biological heterogeneity in CHD and support the study of sex- and menopause-related differences in underlying mechanisms.
PMCID:13676126
PMID: 42893041
ISSN: 2666-6677
CID: 6074846